查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402599

溶瘤病毒治疗市场：按产品类型、按应用、按开发阶段、按分销管道、按地区

Oncolytic Virus Therapy Market, By Product Type, By Application, By Development Stage, By Distribution Channel, By Region
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球溶瘤病毒疗法市场显着成长，预计到 2030 年将达到 4,610 万美元。这比 2023 年的 940 万美元显着增加，反映出 2023 年至 2030 年期间 25.5% 的显着年复合成长率（CAGR）。

报告范围 报告详情
基准年 2022年 2023年市场规模 940万美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 25.50% 2030年市场规模预测 4610 万美元
图 1. 2023 年溶瘤病毒治疗的全球市场占有率(%)（按地区）
溶瘤病毒治疗市场-IMG1

溶瘤病毒疗法是一种很有前景的癌症治疗方法，它利用工程病毒选择性地靶向和破坏癌细胞，同时保护健康细胞。病毒性癌症治疗的概念可以追溯到20世纪初。随着基因工程的进步，该领域在 20 世纪 90 年代获得了发展势头，使科学家能够修改病毒以提高肿瘤特异性和治疗效果。溶瘤病毒可以感染癌细胞并在其中复製，诱导细胞裂解或刺激针对肿瘤的免疫反应。正在进行的研究重点是优化病毒平台、开发联合治疗以及扩大溶瘤病毒疗法在各种癌症类型中的应用。学术界、製药公司和研究机构之间的合作研究有可能推动新型癌症溶细胞病毒疗法的开发，并推动癌症治疗方法。

市场动态：

在病毒工程的进步、对癌症生物学的更好理解、成功的临床试验以及对创新癌症治疗的需求的推动下，全球溶瘤病毒治疗市场正在经历强劲增长。此外，探索新的癌症适应症、改善治疗效果的联合治疗、个人化医疗方法以及开发具有增强特性的下一代病毒预计将在不久的将来提供光明的市场机会。市场趋势包括病毒治疗平台、标靶输送系统和免疫调节策略的进步，以及解决该领域的製造和商业化挑战。此外，市场相关人员正专注于透过合作研究开发新药，预计将推动全球 Oncolyte 病毒治疗市场的成长。例如，2023年6月29日，后期生物製药公司Genelux Corporation和TVAX Biomedical, Inc.宣布，美国专利商标局将主张一种将疫苗增强的过继性T细胞疗法与溶瘤病毒疗法相结合的方法.宣布已获得一项专利该专利独家授权给 V2ACT Therapeutics, LLC，这是 Licensing 和 TVAX 之间的合资企业，旨在开发和测试 V2ACT 免疫疗法。专利到期，之后将进行专利延期，这将为V2ACT免疫疗法增加实质的智慧财产权保护。

然而，有限的临床证据、交付和分销的挑战、与治疗相关的高成本以及治疗的副作用预计将阻碍市场成长。克服这些挑战对于最大限度地提高溶瘤病毒疗法的效率和更广泛地普及至关重要。

本研究的主要特点

  • 本报告对全球溶瘤病毒治疗市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和復合年增长率。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 该报告根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球溶瘤病毒治疗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球溶瘤病毒治疗市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 病毒工程的进展
  • 加深我们对癌症生物学的理解
  • 成功的临床试验结果
  • 创新癌症治疗的需要
  • 治疗费用高昂
  • 治疗的副作用
  • 寻找新的癌症适应症
  • 合併治疗以改善治疗效果
  • 个人化医疗方法
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章溶瘤病毒治疗市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章溶瘤病毒治疗市场，依产品类型，2018-2030

  • 单纯疱疹病毒
  • 腺病毒
  • 痘苗病毒
  • 呼肠孤病毒
  • 麻疹病毒
  • 其他（新城疫病毒、水痘口炎病毒）

第六章溶瘤病毒治疗市场，依应用划分，2018-2030

  • 黑色素瘤
  • 乳癌
  • 头颈癌
  • 膀胱癌
  • 摄护腺癌
  • 肺癌
  • 其他（如大肠直肠癌）

第七章 溶瘤病毒治疗市场，依发展阶段划分，2018-2030

  • 商业的
  • 管道阶段
  • 临床前
  • 第一阶段
  • 第二阶段
  • 第三阶段

第8章溶瘤病毒治疗市场，依通路，2018-2030

  • 医院药房
  • 零售药房
  • 网路药房

第9章溶瘤病毒治疗市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • Amgen Inc.
  • Merck & Co., Inc.
  • Oncolytics Biotech Inc.
  • Circio Holding ASA
  • Akamis Bio
  • Vyriad, Inc.
  • SillaJen Biotherapeutics
  • Cold Genesys Inc.
  • Sorrento Therapeutics, Inc.
  • Takara Bio Inc.
  • Replimune Group Inc.
  • Genelux Corporation
  • Synthetic Biologics, Inc
  • Lokon Pharma AB
  • Elicera Therapeutics

第11章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5916

The global market for oncolytic virus therapy is projected to experience substantial growth, with an estimated value of US$ 46.1 Mn by 2030. This represents a significant increase from US$ 9.4 Mn in 2023, reflecting a remarkable compound annual growth rate (CAGR) of 25.5% during the period of 2023-2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 9.4 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 25.50% 2030 Value Projection: US$ 46.1 Mn
Figure 1. Global Oncolytic Virus Therapy Market Share (%), by Region, 2023
Oncolytic Virus Therapy Market - IMG1

Oncolytic virus therapy is a promising approach to cancer treatment that utilizes modified viruses to selectively target and destroy cancer cells while sparing healthy cells. The concept for viruses for cancer treatment dates back to the early 20th century, when researchers observed tumor regression in patients with viral infections. The field gained momentum in the 1990s with advancements in genetic engineering, enabling scientists to modify viruses to enhance the tumor-specificity and therapeutic efficacy. Oncolytic viruses can infect cancer cells, replicate within them, and induce cell lysis or stimulate immune responses against the tumor. Ongoing research focuses on optimizing viral platforms, developing combination therapies, and expanding the application of oncolytic virus therapy to various cancer types. Collaborations between academia, pharmaceutical companies, and research institutions drive the development of novel oncolytic virus therapies and hold promise for advancing cancer treatment approaches.

Market Dynamics:

The global oncolytic virus therapy market is witnessing strong growth on account of growing advancements in viral engineering, increasing understanding of cancer biology, successful clinical trial results, and the need for innovative cancer treatments. Moreover, exploring new cancer indications, combining therapies for improved outcomes, personalized medicine approaches, and the development of next-generation viruses with enhanced characteristics are expected to bring bright market opportunities in the near future. The market trends include advancements in virotherapy platforms, targeted delivery systems, immune modulation strategies, and addressing manufacturing and commercialization challenges in the field. Moreover, market players are focused on developing novel drugs by collaborating, which is expected to drive the growth of global oncolytic virus therapy market. For instance, on June 29, 2023, Genelux Corporation, a late clinical-stage biopharmaceutical company, and TVAX Biomedical, Inc., a late clinical-stage biopharmaceutical company, announced that the U.S. Patent and Trademark Office granted a patent claiming methods of combining vaccine-enhanced adoptive T cell therapy with oncolytic virus adjunct therapy. The patent has been exclusively licensed to V2ACT Therapeutics, LLC, a joint venture between Genelux and TVAX that was established for the purpose of developing and testing V2ACT immunotherapy. The patent expiry, prior to any patent term extension, will be in 2036 and will add substantial intellectual property protection for V2ACT immunotherapy.

However, limited clinical evidence, delivery and distribution challenges, high costs associated with treatment, and side effects of treatment are expected to hamper market growth. Overcoming these challenges is essential to maximizing the efficiency and broader adoption of oncolytic virus therapies.

Key features of the study:

  • This report provides in-depth analysis of the global oncolytic virus therapy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global oncolytic virus therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study Amgen Inc., Merck & Co., Inc., Oncolytics Biotech Inc., Circio Holding ASA, Akamis Bio, Vyriad, Inc., SillaJen Biotherapeutics, Cold Genesys Inc., Sorrento Therapeutics, Inc., Takara Bio Inc., Replimune Group Inc., Genelux Corporation, Synthetic Biologics, Inc., Lokon Pharma AB, and Elicera Therapeutics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global oncolytic virus therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oncolytic virus therapy market

Detailed Segmentation:

  • Global Oncolytic Virus Therapy Market, By Product Type:
    • Herpes simplex virus
    • Adenovirus
    • Vaccinia virus
    • Reovirus
    • Measles virus
    • Others (Newcastle disease virus, Vesicular stomatitis virus)
  • Global Oncolytic Virus Therapy Market, By Application:
    • Melanoma
    • Breast cancer
    • Head and neck cancer
    • Bladder Cancer
    • Prostate Cancer
    • Lung Cancer
    • Others (Colorectal Cancer, and among Others)
  • Global Oncolytic Virus Therapy Market, By Development Stage:
    • Commercial
    • Pipeline Phase
    • Pre-clinical
    • Phase I
    • Phase II
    • Phase III
  • Global Oncolytic Virus Therapy Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Oncolytic Virus Therapy Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • Amgen Inc.
    • Merck & Co., Inc.
    • Oncolytics Biotech Inc.
    • Circio Holding ASA
    • Akamis Bio
    • Vyriad, Inc.
    • SillaJen Biotherapeutics
    • Cold Genesys Inc.
    • Sorrento Therapeutics, Inc.
    • Takara Bio Inc.
    • Replimune Group Inc.
    • Genelux Corporation
    • Synthetic Biologics, Inc.
    • Lokon Pharma AB
    • Elicera Therapeutics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Oncolytic Virus Therapy Market, By Product Type
    • Global Oncolytic Virus Therapy Market, By Application
    • Global Oncolytic Virus Therapy Market, By Development Stage
    • Global Oncolytic Virus Therapy Market, By Distribution Channel
    • Global Oncolytic Virus Therapy Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Advancements in Viral Engineering
  • Increasing Understanding of Cancer Biology
  • Successful Clinical Trial Results
  • Need for Innovative Cancer Treatments
    • Restraints
  • High cost associated with treatment
  • Side effects of treatment
    • Opportunities
  • Exploring new cancer indications
  • Combining therapies for improved outcomes
  • Personalized medicine approaches
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Oncolytic Virus Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Oncolytic Virus Therapy Market , By Product Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Herpes Simplex Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Adenovirus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Vaccinia virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Reovirus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Measles virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others (Newcastle disease virus, Vesicular stomatitis virus)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Oncolytic Virus Therapy Market , By Application, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Melanoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Breast cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Head and neck cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Bladder Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Prostate Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Mn)
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Others (Colorectal Cancer, and among Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Oncolytic Virus Therapy Market, By Development Stage, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Commercial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Pipeline Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III

8. Oncolytic Virus Therapy Market , By Distribution Channel, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

9. Oncolytic Virus Therapy Market , By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • U.K
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Development Stage, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
  • Oncolytics Biotech Inc.
  • Circio Holding ASA
  • Akamis Bio
  • Vyriad, Inc.
  • SillaJen Biotherapeutics
  • Cold Genesys Inc.
  • Sorrento Therapeutics, Inc.
  • Takara Bio Inc.
  • Replimune Group Inc.
  • Genelux Corporation
  • Synthetic Biologics, Inc
  • Lokon Pharma AB
  • Elicera Therapeutics
  • Analyst Views

11. Section

  • Research Methodology
  • About us